Sunshine Holdings Plc · CSELK:SUN.N0000
Sunshine — Q1 FY2026 Earnings Presentation
37 slides from Sunshine's earnings presentation, Aug 4, 2025
Slide 1: 1QFY26 Earnings Webinar
1QFY26 Earnings Webinar Sunshine Holdings PLC 04 August 2025
Slide 2: Housekeeping Announcements
Housekeeping Announcements • The webinar will be recorded and later uploaded to our IR website as well as CSE website for future reference (https://www.sunshineholdings.lk/investor/financial-reports) • All participants will be muted during the presentation • Participants can use the 'Raise Hand' opt
Slide 3: Group Performance
Group Performance
Slide 4: Group at a Glance – 1QFY26
Group at a Glance – 1QFY26 Revenue Composition – 1QFY26 LKR 2.6bn LKR 1.7bn LKR 0.51 27.6% YoY 20.7% YoY 7.7% YoY Agriculture EBIT Earnings EPS 20.6% 15.7% 20.7% 21.7% LKR 10.06 -6.7 pts YoY -6.6 pts YoY 6.4% YoY LKR 15.9bn Gearing ROE NBV 54.2% Healthcare 30.1% 11.6% 14.0% Consumer 3.7% LKR 51.0bn
Slide 5: Group – Performance Highlights
Group – Performance Highlights LKR m 1QFY26 1QFY25 YoY % 4QFY25 QoQ % Revenue 15,893 14,239 11.6% 14,097 12.7% EBIT 2,645 2,073 27.6% 1,887 40.2% EBIT margin 16.6% 14.6% 13.4% PAT 1,660 1,376 20.7% 1,232 34.8% PAT margin 10.4% 9.7% 8.7% PATMI 1,007 936 7.7% 877 14.9% EPS (LKR) 0.51 0.48 7.7% 0.45 14
Slide 6: Movement in Revenue & EBIT
Movement in Revenue & EBIT Revenue Movement [LKR Million] EBIT Movement [LKR Million] 414 2,645 (24) 111 2,073 70 426 15,893 1,056 172 14,239 1QFY25 Revenue Healthcare Consumer Brands Agriculture 1QFY26 Revenue 1QFY25 EBIT Healthcare Consumer Brands Agriculture Other 1QFY26 EBIT Revenue Composition
Slide 7: A decade of growth
A decade of growth Sunshine Holdings PLC Market Cap (LKRbn) 55.9 51.0 42.3 29.3 22.1 16.4 11.9 6.5 6.8 7.7 7.0 6.2 5.7 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 1QFY26 July 2025 *July Market cap as at 31st July 2025
Slide 8: Healthcare
Healthcare
Slide 9: Sunshine Healthcare Lanka overview
Sunshine Healthcare Lanka (SHL) is Sri Lanka’s only fully integrated healthcare company encompassing the entire pharma value chain Government and Local market Manufacturing and R&D Revenue Split 1QFY26 Sri Lanka’s first facility for Respiratory Care Manufacturing Capsules Tablets Nasal Spray Devices
Slide 10: Healthcare Sector – Highlights
Healthcare Sector – Highlights Sector Highlights 8,569 8,650 8,619 Healthcare sector revenue grew 14.0% YoY in 1QFY26, driven by 7,804 7,563 sustained momentum across the agency, distribution, and retail businesses However, the sector’s overall profitability was impacted by a slowdown in the manufac
Slide 11: Sunshine Pharmaceuticals – Performance Highlights
Sunshine Pharmaceuticals – Performance Highlights Business Highlights 5,385 5,137 4,609 The pharmaceutical segment’s revenue grew by 26.7% YoY in 4,055 4,033 1QFY26, driven by the internal realignment of the business model, as well as continued organic growth across core agency portfolios During IQV
Slide 12: Healthguard Distribution – Performance Highlights
Healthguard Distribution – Performance Highlights Business Highlights 5,869 5,021 5,130 5,177 The Distribution segment’s revenue grew by 44.5% YoY in 1QFY26, driven by a significant volume increase of 47.0% YoY during the 4,062 quarter This volume growth was mainly due to the business model realignm
Slide 13: Sunshine Medical Devices – Performance Highlights
Sunshine Medical Devices – Performance Highlights Business Highlights 1,437 1,251 1,157 1,151 The Medical Devices segment recorded a 17.2% YoY revenue 1,067 growth in 1QFY26, reflecting improved performance during the quarter Excluding tender sales, the segment’s core revenue grew 9.9% YoY in 1QFY26
Slide 14: Lina Manufacturing – Performance Highlights
Lina Manufacturing – Performance Highlights Business Highlights 1,459 During 1QFY26, revenue from the manufacturing business declined 1,128 1,095 by 19.6% YoY, primarily due to the timing of government delivery 906 schedules and the execution of new MDI machine validation processes during the quarte
Slide 15: Healthguard Pharmacy – Performance Highlights
Healthguard Pharmacy – Performance Highlights Business Highlights 735 713 The retail segment, Healthguard Pharmacy, recorded a 17.4% YoY 694 increase in revenue for 1QFY26, driven by volume and value growth 666 across both pharmaceutical and wellness ranges 626 1QFY25 2QFY25 3QFY25 4QFY25 1QFY26 Rev
Slide 16: Consumer Brands
Consumer Brands
Slide 17: Sunshine Consumer overview
Sunshine Consumer, Market leader in branded tea and sugar confectionery Brand Portfolio Revenue Split 1QFY26 Tea Inter Co. / Other Largest branded tea company in Sri Lanka – 48% market share* *Peppercube Retail Measurement Survey Exports -2% Tea Catering to three distinct need and value segments, th
Slide 18: Consumer Sector – Highlights
Consumer Sector – Highlights Sector Highlights 5,056 4,609 4,708 4,781 The Consumer sector, including both export and domestic 4,373 businesses, recorded a 3.7% YoY revenue growth in 1QFY26, supported improvements in both domestic and export markets 328 377 277 279 169 1QFY25 2QFY25 3QFY25 4QFY25 1Q
Slide 19: Tea – Performance Highlights
Tea – Performance Highlights Business Highlights Revenue from the Branded Tea business grew marginally by 1.5% YoY 2,454 2,429 2,433 to LKR 2.3 Bn in 1QFY26, driven by focused trade and consumer activation initiatives 2,276 2,242 Our core tea brands, Watawala Thei and Zesta, continued to perform wel
Slide 20: Confectionery – Performance Highlights
Confectionery – Performance Highlights Business Highlights 589 Revenue from the Confectionery business improved significantly by 529 19.9% YoY in 1QFY26, supported by both volume and value growth 494 441 during the period, where successful new product introductions 404 contributed to this momentum 1
Slide 21: Exports – Performance Highlights
Exports – Performance Highlights Business Highlights 2,038 2,066 The export business recorded a 7.2% YoY revenue increase in 1,926 1,851 1QFY26, reaching LKR 2.1 Bn, driven by continued demand from 1,532 key international clients 1QFY25 2QFY25 3QFY25 4QFY25 1QFY26 Revenue (LKR Mn) Investor Metrics 1
Slide 22: Agribusiness
Agribusiness
Slide 23: Watawala Plantations overview
Watawala Plantations PLC primarily engages in palm oil and dairy farming Revenue Split 1QFY26 Palm Oil A land extent of ~3,400 Ha under palm oil cultivation Dairy 11% The first in South Asia to receive RSPO certification for sustainable oil palm plantation Positioning – largest oil palm cultivator i
Slide 24: Agribusiness – Highlights
Agribusiness – Highlights Sector Highlights 2,492 2,193 The Agribusiness sector reported revenue of LKR 2.5 Bn in 2,065 1,919 1QFY26, reflecting a 20.6% YoY improvement, driven by the 1,767 performance of the palm oil business 1,216 However, this improvement was partially offset by a decline in 802
Slide 25: Palm Oil – Performance Highlights
Palm Oil – Performance Highlights Business Highlights 2,213 The Palm Oil segment recorded a 27.2% YoY improvement in 1,902 1,739 revenue in 1QFY26, driven by better pricing and higher sales 1,652 1,468 volumes, as result of increased crop processing and improved oil extraction rates 1,231 968 766 66
Slide 26: Dairy – Performance Highlights
Dairy – Performance Highlights 326 Business Highlights 291 299 279 267 The dairy business recorded a 14.6% YoY revenue decline in 1QFY26, driven by reductions in both volumes and milk selling prices 37 38 1 -44 -15 1QFY25 2QFY25 3QFY25 4QFY25 1QFY26 Revenue (LKR Mn) EBIT (LKR Mn) Investor Metrics 1Q
Slide 27: Q&A
Q&A
Slide 28: Appendix
Appendix
Slide 29: Sunshine Pharmaceuticals – Market Dynamics
Sunshine Pharmaceuticals – Market Dynamics During 1Q IQVIA, the market experienced a growth of 5.1% (2025 MAT%) 13.0% 13.0% 30% 14% 27.9% 12.8% 14% 26.7% 13% 13% 25% 12.7% 12% 12% 10.4% 11% 11% 10% 10% 20% 17.5% 17.5% 9% 16.9% 9% 8% 14.3% 8% 15% 14.1% 7% 12.0% 7% 6% 10.5% 6% 5% 8.1% 10% 5% 4% 4% 5.0
Slide 30: Pharmaceuticals – Price Increase Index
Pharmaceuticals – Price Increase Index 190 3 30 3 25 325 326 180 324 322 323 3 20 170 321 319 3 15 160 152 152 152 152 152 152 152 152 152 313 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 152 3 10 150 309 3 05 306 304 304 140 302 3 00 301 301 300 130 299 300 299 299 296 297 296 2 95 1
Slide 31: Sunshine Medical Devices – Market Dynamics
Sunshine Medical Devices – Market Dynamics 91% 90% 88% 88% 88% 86% 86% 81% 82% 81% 81% 80% 79% 79% 77% 77% 77% 76% 75% 70% 73% 3QFY24 4QFY24 1QFY25 2QFY25 3QFY25 4QFY25 1QFY26 Hospital Occupancy Lab Tests Operation Theaters Source – Management Information
Slide 32: Brand Value Market Share (%) – Tea
Brand Value Market Share (%) – Tea 100.0 90.0 22 19 20 24 23 23 23 26 26 28 28 30 27 27 27 28 28 27 27 29 29 28 29 32 31 80.0 9 10 8 8 9 9 9 70.0 9 9 6 6 6 5 5 5 5 5 5 8 7 6 5 4 6 7 60.0 50.0 47 49 49 46 46 46 45 47 45 45 47 48 48 49 49 49 48 48 48 48 40.0 45 46 44 45 47 30.0 20.0 10.0 23 23 22 21 2
Slide 33: Brand Value Market Share (%) – Confectionary
Brand Value Market Share (%) – Confectionary 100.0 90.0 22 22 22 22 22 22 23 24 23 23 24 24 80.0 70.0 19.0 18.5 18.3 16.3 15.4 14.7 14.4 20.7 20.5 19.5 17.7 17.6 Market Share % 60.0 50.0 36.8 36.1 34.9 34.3 35.1 36.7 35.6 37.2 40.0 38.0 36.6 35.0 36.0 30.0 20.0 22.4 22.0 22.7 23.8 24.0 23.9 25.5 24.
Slide 34: Price Index – Tea and Confectionary
Price Index – Tea and Confectionary Tea Price Index Confectionery Price Index 230 190 214 210 203 203 203 203 203 203 203 203 203 203 203 203 203 203 203 170 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167 167167 193 193 193 164 190 159 150 151
Slide 35: Agribusiness – Price Movement
Agribusiness – Price Movement Settlement Price (RM) WDL's Avg Milk Price (LKR) 5,500 270 260 260 5,000 250 MALAYSIAN RINGGITS – RM 4,500 240 4,000 4,037 229 230 3,913 3,500 220 3,000 210 2,500 200 Jul-24 Aug-24 Sep-24 Oct-24 Nov-24 Dec-24 Jan-25 Feb-25 Mar-25 Apr-25 May-25 Jun-25 June-24 August-24 O
Slide 36: Forward Looking Statements
Forward Looking Statements This presentation contains forward-looking statements that are based on management’s current expectations and assumptions. Forward-looking statements include predictions of future results or activities and may contain the words “expects,” “believes,” “should,” “will,” “ant
Slide 37: Thank you!
Thank you! For more information, Please visit our Investor Relations page https://www.sunshineholdings.lk/investor/financial-reports